CLX
CloroxPrevious close
84.86
Change
−2.30 / −2.64%
52-Week Range
84.70 – 128.90
P/E (TTM)
17.8
Forward P/E
16.2
Based on consensus earnings for the next 12 months
Market Cap
$10.3B
1M
−19.90%
S&P 500 −2.41% over same period
Volume / Avg Volume
3.4M / 3.0M
1.15× average
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | EPS Actual / Est. | Analysis |
|---|---|---|---|---|
| FY2026 Q4 Quarter ended 2026-06 | 2026-08-03 | $1.9B | 1.66 / 1.67 | Read analysis → |
| FY2026 Q3 Quarter ended 2026-03 | 2026-04-30 | $1.7B | 1.64 / 1.57 | Pending |
| FY2026 Q2 Quarter ended 2025-12 | 2026-02-03 | — | — / — | Pending |
| FY2026 Q1 Quarter ended 2025-09 | 2025-11-03 | — | — / — | Pending |
| FY2025 Q4 Quarter ended 2025-06 | 2025-07-31 | — | — / — | Pending |
| FY2025 Q3 Quarter ended 2025-03 | 2025-05-05 | — | — / — | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 23 of its 5-year rangeCheap
5-year range 15.4 – 264.0 · Median 55.7
Last 4 quarters: $331M in buybacks + $602M in dividends, 9.09% of market cap combined
P/E (TTM)
17.8
P/B
—
P/S
1.6
Dividend Yield
3.40%
Earnings Reaction
Over the last 6 reports, the stock moved ±4.0% on average on the first trading day after, rising 3 times
Most recent +6.52%
Volatility & Correlation
1-year beta 0.24 · Correlation with S&P 500 0.10Low beta
Annualized volatility 31% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q3 | 1.67 | +0.1% | 43.2% | 0.19 | 1.54 |
| FY2026 Q2 | 1.67 | −0.8% | 43.2% | 0.16 | 1.29 |
| FY2026 Q1 | 1.43 | −18.9% | 41.7% | 0.08 | 0.65 |
| FY2025 Q4 | 1.99 | +4.5% | 46.5% | 0.33 | 2.68 |
| FY2025 Q3 | 1.67 | −8.0% | 44.6% | 0.19 | 1.50 |
| FY2025 Q2 | 1.69 | −15.3% | 43.8% | 0.19 | 1.54 |
| FY2025 Q1 | 1.76 | +27.1% | 45.8% | 0.10 | 0.80 |
| FY2024 Q4 | 1.90 | −5.7% | 46.5% | 0.22 | 1.74 |
| FY2024 Q3 | 1.81 | −5.3% | 42.2% | -0.05 | -0.41 |
| FY2024 Q2 | 1.99 | +16.0% | 43.5% | 0.09 | 0.75 |
| FY2024 Q1 | 1.39 | −20.3% | 38.4% | 0.02 | 0.17 |
| FY2023 Q4 | 2.02 | +12.1% | 42.7% | 0.18 | 1.43 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| CLX | 17.8 | +0.1% | 43.2% | −19.90% | Bearish |
| WMT | 38.5 | +5.9% | 25.4% | −5.97% | Neutral |
| COST | 45.2 | +11.6% | 12.8% | −6.27% | Bullish |
| KO | 26.6 | −0.5% | 63.0% | +1.02% | Neutral |
| PG | 21.2 | +1.5% | 48.5% | +2.72% | Neutral |
| PM | 27.8 | +10.4% | 68.4% | +3.90% | Neutral |
| PEP | 17.7 | +6.4% | 54.2% | −2.82% | Neutral |
| MO | 14.6 | +0.1% | 74.9% | +9.60% | Neutral |
| MNST | 41.3 | +20.2% | 55.9% | −2.09% | Neutral |